Article from the Australian Medical Association.
Quote: " World AMR Awareness Week alerts us to one of the most serious global health threats of the 21st century "
IMO, LDX has identified a highly notable need in the fight against antimicrobial resistance and has established itself with a ready to use product (FebriDx) within a market that is desperate for solutions.
IMO, the fact that the US Department of Health and Human Services (BARDA) has provided LDX with up to US 8.3 million in funding and support is a reflection of the endorsement that LDX has from policy makers in the fight against AMR.
IMO, that support will only become more substantive overtime, and will highly likely come more governments around the world, including Australia.
Link to Article: https://www.ama.com.au/media/awareness-week-highlights-danger-drug-resistant-superbugs
Add to My Watchlist
What is My Watchlist?
